• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈锥切术后切缘状态可预测以西班牙裔为主的人群中残留的原位腺癌(AIS)及隐匿性腺癌。

Margin Status Post Cervical Conization Predicts Residual Adenocarcinoma In Situ (AIS) and Occult Adenocarcinoma in a Predominantly Hispanic Population.

作者信息

Hong Linda J, Huynh Sandy, Kim Joy, Denham Laura, Momeni Mazdak, Ioffe Yevgeniya J M

机构信息

Department of Obstetrics & Gynecology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA.

Department of Obstetrics & Gynecology, Southern California Permanente Medical Group, Fontana, CA 92335, USA.

出版信息

Diagnostics (Basel). 2021 Oct 13;11(10):1889. doi: 10.3390/diagnostics11101889.

DOI:10.3390/diagnostics11101889
PMID:34679587
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8534706/
Abstract

Adenocarcinoma in situ (AIS) of the cervix, is increasing in incidence, particularly in women of reproductive age. Fertility preservation is often desired. In a predominantly Hispanic population, we sought to determine the incidence of occult cervical cancer co-existing with AIS, and evaluate how conization margin status correlates with residual disease upon hysterectomy. A retrospective study utilizing a comprehensive cancer center database was conducted. Data from patients with histologically proven AIS of the cervix were abstracted. Of 47 patients that met the criteria, 23 (49%) were Hispanic, 21 (45%) were White, two (4%) were Asian, and one (2%) was Black. The median age was 37. Forty-two patients underwent cervical conizations; 13/42 (48%) had positive margins upon conization; 28/42 (67%) underwent hysterectomies. Furthermore, 6/13 (46%) patients with positive conization margins had residual disease in hysterectomy specimens, with 2/13 (15%) found to have invasive cancer. In contrast, 0/14 (0%) of patients with negative margins had residual disease ( = 0.036, Chi-squared 4.41, df = 1). In total, 2/27 (7%) patients who underwent hysterectomies had invasive cancer (7%). Positive margins upon cervical conization for AIS of the cervix were correlated with a relatively high rate of residual AIS and occult invasive cancer. Negative conization margins were correlated with no residual disease. Those patients may be candidates for fertility-sparing treatment.

摘要

宫颈原位腺癌(AIS)的发病率正在上升,尤其是在育龄女性中。保留生育功能通常是患者所期望的。在以西班牙裔为主的人群中,我们试图确定与AIS共存的隐匿性宫颈癌的发病率,并评估锥切切缘状态与子宫切除术后残留疾病的相关性。我们利用一个综合癌症中心数据库进行了一项回顾性研究。提取了经组织学证实为宫颈AIS患者的数据。在符合标准的47例患者中,23例(49%)为西班牙裔,21例(45%)为白人,2例(4%)为亚洲人,1例(2%)为黑人。中位年龄为37岁。42例患者接受了宫颈锥切术;其中13/42(48%)锥切切缘阳性;28/42(67%)接受了子宫切除术。此外,13例锥切切缘阳性的患者中有6例(46%)子宫切除标本中有残留疾病,其中2/13(15%)被发现患有浸润癌。相比之下,切缘阴性的患者中0/14(0%)有残留疾病(P = 0.036,卡方检验4.41,自由度 = 1)。总共2/27(7%)接受子宫切除术的患者患有浸润癌(7%)。宫颈AIS锥切切缘阳性与残留AIS和隐匿性浸润癌的相对高发生率相关。锥切切缘阴性与无残留疾病相关。这些患者可能是保留生育功能治疗的候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb32/8534706/384f0f4b620c/diagnostics-11-01889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb32/8534706/264029b13665/diagnostics-11-01889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb32/8534706/384f0f4b620c/diagnostics-11-01889-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb32/8534706/264029b13665/diagnostics-11-01889-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb32/8534706/384f0f4b620c/diagnostics-11-01889-g002.jpg

相似文献

1
Margin Status Post Cervical Conization Predicts Residual Adenocarcinoma In Situ (AIS) and Occult Adenocarcinoma in a Predominantly Hispanic Population.宫颈锥切术后切缘状态可预测以西班牙裔为主的人群中残留的原位腺癌(AIS)及隐匿性腺癌。
Diagnostics (Basel). 2021 Oct 13;11(10):1889. doi: 10.3390/diagnostics11101889.
2
[Risk stratified management of cervical adenocarcinoma in situ based on cone margin state].基于锥切边缘状态的宫颈原位腺癌风险分层管理
Zhonghua Fu Chan Ke Za Zhi. 2021 Sep 25;56(9):622-629. doi: 10.3760/cma.j.cn112141-20210802-00417.
3
Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.子宫颈原位癌和早期浸润性腺癌的保留生育功能治疗
Obstet Gynecol. 2001 Nov;98(5 Pt 1):726-31. doi: 10.1016/s0029-7844(01)01544-7.
4
Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.接受环形电切术/锥切术治疗原位腺癌的女性发生残留原位腺癌或宫颈腺癌的风险。
J Reprod Med. 2011 Sep-Oct;56(9-10):376-80.
5
Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.宫颈锥切术后切缘阳性时子宫切除术中残留癌或原位癌的预测因素。
Gynecol Oncol. 2014 Jan;132(1):76-80. doi: 10.1016/j.ygyno.2013.11.019. Epub 2013 Nov 19.
6
Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.宫颈原位腺癌锥切切缘的充分性作为残留疾病的预测指标
Gynecol Oncol. 1995 Nov;59(2):179-82. doi: 10.1006/gyno.1995.0003.
7
Exploring uterine involvement in hysterectomy samples following conization for adenocarcinoma in situ of the uterine cervix: Insights from a multicenter study by the FRANCOGYN group.探讨子宫颈原位腺癌锥切术后子宫切除标本中子宫受累情况:FRANCOGYN 多中心研究的新见解。
J Gynecol Obstet Hum Reprod. 2024 Nov;53(9):102826. doi: 10.1016/j.jogoh.2024.102826. Epub 2024 Jul 27.
8
The safety of conization in the management of adenocarcinoma in situ of the uterine cervix.宫颈原位腺癌管理中锥切术的安全性。
J Gynecol Oncol. 2011 Mar 31;22(1):25-31. doi: 10.3802/jgo.2011.22.1.25.
9
Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.锥切术中进行宫颈管刮除术以预测残留的宫颈原位腺癌。
Gynecol Oncol. 2002 Oct;87(1):129-32. doi: 10.1006/gyno.2002.6791.
10
Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.宫颈原位腺癌患者锥形切除术后的临床结局
Eur J Gynaecol Oncol. 2014;35(6):641-5.

引用本文的文献

1
The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia-A Review.阴道微生物群、人乳头瘤病毒与宫颈发育异常——综述
Medicina (Kaunas). 2025 May 5;61(5):847. doi: 10.3390/medicina61050847.
2
Reproducibility of colposcopy quality indicators-A survey among members of the European Federation for Colposcopy.阴道镜质量指标的可重复性——欧洲阴道镜学会成员的调查。
Acta Obstet Gynecol Scand. 2024 Sep;103(9):1745-1752. doi: 10.1111/aogs.14895. Epub 2024 Jun 24.

本文引用的文献

1
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南。
J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525.
2
Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.《原位腺癌的诊断与管理:妇科肿瘤学学会循证综述与推荐》。
Obstet Gynecol. 2020 Apr;135(4):869-878. doi: 10.1097/AOG.0000000000003761.
3
Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study.
宫颈原位腺癌女性的管理与长期结局:一项回顾性研究。
Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):123-129. doi: 10.1111/ajo.13047. Epub 2019 Oct 3.
4
Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.宫颈原位腺癌:2008-2015 年五个州的人乳头瘤病毒类型和发病趋势。
Int J Cancer. 2020 Feb 1;146(3):810-818. doi: 10.1002/ijc.32340. Epub 2019 May 6.
5
Risk of persistent or recurrent cervical neoplasia in patients with 'pure' adenocarcinoma-in-situ (AIS) or mixed AIS and high-grade cervical squamous neoplasia (cervical intra-epithelial neoplasia grades 2 and 3 (CIN 2/3)): a population-based study.“单纯”腺癌原位(AIS)或 AIS 合并高级别宫颈鳞状上皮内瘤变(宫颈上皮内瘤变 2/3 级(CIN2/3))患者持续性或复发性宫颈上皮内瘤变的风险:一项基于人群的研究。
BJOG. 2018 Jan;125(1):74-79. doi: 10.1111/1471-0528.14808. Epub 2017 Aug 2.
6
Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ.偶然发现原位腺癌后持续和复发的宫颈上皮内瘤变风险。
Am J Obstet Gynecol. 2017 Mar;216(3):272.e1-272.e7. doi: 10.1016/j.ajog.2016.11.1044. Epub 2016 Nov 28.
7
Adenocarcinoma in situ of the uterine cervix--a systematic review.子宫颈原位腺癌——一项系统评价
Int J Gynecol Cancer. 2014 Nov;24(9):1543-8. doi: 10.1097/IGC.0000000000000260.
8
Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.宫颈原位腺癌锥切:残留疾病的预测模型。
Am J Obstet Gynecol. 2014 Apr;210(4):366.e1-366.e5. doi: 10.1016/j.ajog.2013.12.030. Epub 2013 Dec 24.
9
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.宫颈原位腺癌治疗后残留疾病和浸润性癌的风险。
Gynecol Oncol. 2013 Jun;129(3):513-6. doi: 10.1016/j.ygyno.2013.03.015. Epub 2013 Mar 28.
10
Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.美国男女人群中的性传播感染:2008 年的流行率和发病率估计。
Sex Transm Dis. 2013 Mar;40(3):187-93. doi: 10.1097/OLQ.0b013e318286bb53.